At the Lab
Each episode features a CSHL researcher or educator focused on the biggest global issues and scientific mysteries of the past, present, and future—from deadly diseases to climate change.
Tune in to hear our latest bioscience breakthrough broken down in 3 minutes or less.
Subscribe: Apple | Podbean | Spotify | YouTube | Amazon Alexa device
At the Lab: Catch me if you cancer
You’ve seen her on FOX and the cover of Newsday. Now, hear about the knowledge gaps that make her discovery so crucial and the noble goals driving it.
At the Lab: The human Microprocessor
There’s a Microprocessor inside you. Actually, there are trillions. Only they’re not computer processors. They’re much smaller and far more complex.
At the Lab: AI evolves
CSHL neuroscientists discuss the biological brain’s multibillion-year advantage over AI—and the new algorithm they built based on that concept.
At the Lab: UTIs in women’s health
Why do breast cancer researchers focused on pregnancy start looking into urinary tract infections? The backstory is as intriguing as the story itself.
At the Lab: The nuclear speckle option
Speckles sound innocent enough, like little spots. But don’t be fooled. These tiny structures could someday have big implications for cancer care.
At the Lab: Dancing with fire
What happens to our brain receptors’ “dance routines” when the brain comes under immune system attack? Tune in to find out.
At the Lab: Products of an unseen environment
You may have read about their fascinating research in
At the Lab: Science for lovers
You can’t spell evolution without l-o-v-e. A tale of passion and curiosity takes us from New York to Australia, France, the U.K., and South America.
At the Lab: A vitamin for prostate cancer
For the Season 2 premiere of our podcast, we sit down with CSHL Professor Lloyd Trotman to discuss what could be a major breakthrough in men’s health.
At the Lab Season 1 Research Rewind: AI+
This season’s final Research Rewind brings us from the realm of quantitative biology to neuroscience, genomics, and beyond.